<< Back
Nov 19, 2019

Omnicell Announces Annual Innovation Day for Investors and Analysts

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Nov. 19, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced they will host an Investor and Analyst meeting at the Annual ASHP Midyear Meeting on December 10, 2019.

ANNUAL ASHP MIDYEAR MEETING

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO; Peter Kuipers, executive vice president & CFO; Scott Seidelmann, executive vice president & CCO

Date: Tuesday, December 10, 2019
Time: 8:00 a.m.11:00 a.m. PT
Location: Mandalay Bay North Convention Center, Las Vegas, NVTropics Ballroom

Agenda:

8:00 a.m. – Presentation and Q&A. For call in and replay details please see below:

The innovation presentation and Q&A can be monitored by dialing 1-844-358-6756 within the U.S. or 1-216-562-0399 for all other locations. The Conference ID # is 8433147. The webcast can be accessed at: http://ir.omnicell.com/communications/events-presentations. A replay will be available starting at 1:00 p.m. PT on December 10, 2019 through 12:00 p.m. PT on December 17, 2019. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 8433147.

10:00 a.m. – Booth Tour and Demonstration for Investors and Analysts attending in person at Booth #1018.

For Investors interested in attending this event in person, please email Michelle Smith at michelle.smith@omnicell.com

About Omnicell

Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications across all care settings. Through its industry-leading medication management platform that spans the continuum of care, Omnicell is developing a vision for a fully automated infrastructure, powered by a cloud data platform that supports improved patient care, fewer errors, enhanced safety, and new opportunities for growth.

Omnicell's vision for the Autonomous Pharmacy integrates a comprehensive set of solutions across three key areas: automation solutions designed to digitize and streamline workflows; intelligence that provides actionable insights to better understand medication usage and improve pharmacy supply chain management; and work - expert services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes.

Over 5,500 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence solutions designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

To learn more about Omnicell and its Autonomous Pharmacy vision, please visit omnicell.com.

OMCL-E

Source: Omnicell, Inc.

Peter Kuipers
Chief Financial Officer
800-850-6664, ext. 6180
peter.kuipers@omnicell.com